Loading…
Relationship between elevated circulating thrombospondin‐1 levels and vascular complications in diabetes mellitus
Aims/Introduction Thrombospondin‐1 (TSP‐1) participates in a series of physiological and pathological processes by binding to various receptors regulating cell proliferation, adhesion and apoptosis. Elevated circulating TSP‐1 is linked with diabetic vascular complications (DVC). This study aimed to...
Saved in:
Published in: | Journal of diabetes investigation 2024-02, Vol.15 (2), p.197-207 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c5105-b47523bcbd496aeb9f7cdc42bc91cebc1dfbc7360a65aedc8c685d288c4483103 |
---|---|
cites | cdi_FETCH-LOGICAL-c5105-b47523bcbd496aeb9f7cdc42bc91cebc1dfbc7360a65aedc8c685d288c4483103 |
container_end_page | 207 |
container_issue | 2 |
container_start_page | 197 |
container_title | Journal of diabetes investigation |
container_volume | 15 |
creator | Guo, Na Yang, Linlin Wan, Xiaozheng Qiu, Dongze Sun, Wenwen Ma, Huijuan |
description | Aims/Introduction
Thrombospondin‐1 (TSP‐1) participates in a series of physiological and pathological processes by binding to various receptors regulating cell proliferation, adhesion and apoptosis. Elevated circulating TSP‐1 is linked with diabetic vascular complications (DVC). This study aimed to determine the relationship between circulating TSP‐1 levels and DVC.
Materials and Methods
A comprehensive search of PubMed, Embase, Web of Science and CNKI databases was carried out. A meta‐analysis was carried out to compare circulating TSP‐1 levels between diabetes patients without vascular complications (DNVC), diabetes patients with DVC and non‐diabetes patients. The correlation between TSP‐1 and metabolic parameters was also analyzed. Subgroup analysis was carried out according to complication type, defined as diabetic retinopathy, diabetic nephropathy and diabetic cardiovascular disease (DCVD).
Results
A total of eight studies were included. Compared with non‐diabetes patients, diabetic patients, including DNVC and DVC, had significantly higher circulating TSP‐1 levels (standardized mean difference [SMD] 2.660, 95% CI 1.17–4.145, P = 0.000). DNVC had significantly higher circulating TSP‐1 levels than non‐diabetes patients (SMD 3.613, 95% CI 1.607–5.619, P = 0.000). DVC had significantly higher TSP‐1 levels than DNVC (SMD 0.568, 95% CI 0.100–1.036, P = 0.017). TSP‐1 was significantly positively correlated with fasting plasma glucose (overall Fisher's z = 0.696, 95% CI 0.559–0.833) and HbA1c (overall Fisher's z = 0.849, 95% CI 0.776–0.923).
Conclusions
Elevated circulating TSP‐1 levels are closely related to DVC, especially in diabetic nephropathy and diabetic cardiovascular disease. Circulating TSP‐1 detection might be helpful in the timely diagnosis and treatment of DVC.
This article studied the relationship between circulating thrombospondin‐1 levels and diabetic vascular complications by means of meta‐analysis to provide a target for the diagnosis and treatment of diabetic vascular complications |
doi_str_mv | 10.1111/jdi.14095 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_ea673f5d29694704afed446192d0f469</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_ea673f5d29694704afed446192d0f469</doaj_id><sourcerecordid>2876637445</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5105-b47523bcbd496aeb9f7cdc42bc91cebc1dfbc7360a65aedc8c685d288c4483103</originalsourceid><addsrcrecordid>eNp1kt9qFDEUhwdRbKm98AUk4I1ebJtkMvlzJdJaXSkIotchk5zZzTKTrMnMlt75CD5jn8Rspy5W8NwkJF--HA6_qnpJ8Bkpdb5x_owwrJon1THFDC8IoezpYU_4UXWa8waXqqXkXDyvjmohKSVSHFf5K_Rm9DHktd-iFsYbgICgh50ZwSHrk532QFihcZ3i0Ma8jcH5cPfzF0EFgz4jExzambwnE7Jx2PbezlLkA3LeFC9kNEDf-3HKL6pnnekznD6sJ9X3qw_fLj4trr98XF68v17YhuBm0TLR0Lq1rWOKG2hVJ6yzjLZWEQutJa5rrag5Nrwx4Ky0XDaOSmkZkzXB9Um1nL0umo3eJj-YdKuj8fr-IKaVNmn0tgcNhou6K68VV0xgZjpwjHGiqMMd46q43s2u7dQO5TMIYzL9I-njm-DXehV3mmCJmcK8GN48GFL8MUEe9eCzLSMxAeKUNZWC81ow1hT09T_oJk4plFlpqohoiJRkT72dKZtizgm6QzcE6300dImGvo9GYV_93f6B_BOEApzPwI3v4fb_Jv35cjkrfwNBlcaL</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2917518815</pqid></control><display><type>article</type><title>Relationship between elevated circulating thrombospondin‐1 levels and vascular complications in diabetes mellitus</title><source>Open Access: Wiley-Blackwell Open Access Journals</source><source>Publicly Available Content (ProQuest)</source><source>PubMed Central</source><creator>Guo, Na ; Yang, Linlin ; Wan, Xiaozheng ; Qiu, Dongze ; Sun, Wenwen ; Ma, Huijuan</creator><creatorcontrib>Guo, Na ; Yang, Linlin ; Wan, Xiaozheng ; Qiu, Dongze ; Sun, Wenwen ; Ma, Huijuan</creatorcontrib><description>Aims/Introduction
Thrombospondin‐1 (TSP‐1) participates in a series of physiological and pathological processes by binding to various receptors regulating cell proliferation, adhesion and apoptosis. Elevated circulating TSP‐1 is linked with diabetic vascular complications (DVC). This study aimed to determine the relationship between circulating TSP‐1 levels and DVC.
Materials and Methods
A comprehensive search of PubMed, Embase, Web of Science and CNKI databases was carried out. A meta‐analysis was carried out to compare circulating TSP‐1 levels between diabetes patients without vascular complications (DNVC), diabetes patients with DVC and non‐diabetes patients. The correlation between TSP‐1 and metabolic parameters was also analyzed. Subgroup analysis was carried out according to complication type, defined as diabetic retinopathy, diabetic nephropathy and diabetic cardiovascular disease (DCVD).
Results
A total of eight studies were included. Compared with non‐diabetes patients, diabetic patients, including DNVC and DVC, had significantly higher circulating TSP‐1 levels (standardized mean difference [SMD] 2.660, 95% CI 1.17–4.145, P = 0.000). DNVC had significantly higher circulating TSP‐1 levels than non‐diabetes patients (SMD 3.613, 95% CI 1.607–5.619, P = 0.000). DVC had significantly higher TSP‐1 levels than DNVC (SMD 0.568, 95% CI 0.100–1.036, P = 0.017). TSP‐1 was significantly positively correlated with fasting plasma glucose (overall Fisher's z = 0.696, 95% CI 0.559–0.833) and HbA1c (overall Fisher's z = 0.849, 95% CI 0.776–0.923).
Conclusions
Elevated circulating TSP‐1 levels are closely related to DVC, especially in diabetic nephropathy and diabetic cardiovascular disease. Circulating TSP‐1 detection might be helpful in the timely diagnosis and treatment of DVC.
This article studied the relationship between circulating thrombospondin‐1 levels and diabetic vascular complications by means of meta‐analysis to provide a target for the diagnosis and treatment of diabetic vascular complications</description><identifier>ISSN: 2040-1116</identifier><identifier>ISSN: 2040-1124</identifier><identifier>EISSN: 2040-1124</identifier><identifier>DOI: 10.1111/jdi.14095</identifier><identifier>PMID: 37822187</identifier><language>eng</language><publisher>Japan: John Wiley & Sons, Inc</publisher><subject>Apoptosis ; Bias ; Cardiovascular disease ; Cardiovascular diseases ; Case reports ; Cell proliferation ; Confidence intervals ; Diabetes ; Diabetes complications ; Diabetes mellitus ; Diabetic nephropathy ; Diabetic retinopathy ; Extracellular matrix ; Glucose ; Kidneys ; Meta-analysis ; Metabolism ; Nephropathy ; Original ; Retinopathy ; Sensitivity analysis ; Statistical analysis ; Thrombospondin ; Thrombospondin‐1</subject><ispartof>Journal of diabetes investigation, 2024-02, Vol.15 (2), p.197-207</ispartof><rights>2023 The Authors. published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd.</rights><rights>2023 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd.</rights><rights>2024. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5105-b47523bcbd496aeb9f7cdc42bc91cebc1dfbc7360a65aedc8c685d288c4483103</citedby><cites>FETCH-LOGICAL-c5105-b47523bcbd496aeb9f7cdc42bc91cebc1dfbc7360a65aedc8c685d288c4483103</cites><orcidid>0000-0002-4176-5013 ; 0009-0005-3214-8995</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2917518815/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2917518815?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,11560,25751,27922,27923,37010,37011,44588,46050,46474,53789,53791,74896</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37822187$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Guo, Na</creatorcontrib><creatorcontrib>Yang, Linlin</creatorcontrib><creatorcontrib>Wan, Xiaozheng</creatorcontrib><creatorcontrib>Qiu, Dongze</creatorcontrib><creatorcontrib>Sun, Wenwen</creatorcontrib><creatorcontrib>Ma, Huijuan</creatorcontrib><title>Relationship between elevated circulating thrombospondin‐1 levels and vascular complications in diabetes mellitus</title><title>Journal of diabetes investigation</title><addtitle>J Diabetes Investig</addtitle><description>Aims/Introduction
Thrombospondin‐1 (TSP‐1) participates in a series of physiological and pathological processes by binding to various receptors regulating cell proliferation, adhesion and apoptosis. Elevated circulating TSP‐1 is linked with diabetic vascular complications (DVC). This study aimed to determine the relationship between circulating TSP‐1 levels and DVC.
Materials and Methods
A comprehensive search of PubMed, Embase, Web of Science and CNKI databases was carried out. A meta‐analysis was carried out to compare circulating TSP‐1 levels between diabetes patients without vascular complications (DNVC), diabetes patients with DVC and non‐diabetes patients. The correlation between TSP‐1 and metabolic parameters was also analyzed. Subgroup analysis was carried out according to complication type, defined as diabetic retinopathy, diabetic nephropathy and diabetic cardiovascular disease (DCVD).
Results
A total of eight studies were included. Compared with non‐diabetes patients, diabetic patients, including DNVC and DVC, had significantly higher circulating TSP‐1 levels (standardized mean difference [SMD] 2.660, 95% CI 1.17–4.145, P = 0.000). DNVC had significantly higher circulating TSP‐1 levels than non‐diabetes patients (SMD 3.613, 95% CI 1.607–5.619, P = 0.000). DVC had significantly higher TSP‐1 levels than DNVC (SMD 0.568, 95% CI 0.100–1.036, P = 0.017). TSP‐1 was significantly positively correlated with fasting plasma glucose (overall Fisher's z = 0.696, 95% CI 0.559–0.833) and HbA1c (overall Fisher's z = 0.849, 95% CI 0.776–0.923).
Conclusions
Elevated circulating TSP‐1 levels are closely related to DVC, especially in diabetic nephropathy and diabetic cardiovascular disease. Circulating TSP‐1 detection might be helpful in the timely diagnosis and treatment of DVC.
This article studied the relationship between circulating thrombospondin‐1 levels and diabetic vascular complications by means of meta‐analysis to provide a target for the diagnosis and treatment of diabetic vascular complications</description><subject>Apoptosis</subject><subject>Bias</subject><subject>Cardiovascular disease</subject><subject>Cardiovascular diseases</subject><subject>Case reports</subject><subject>Cell proliferation</subject><subject>Confidence intervals</subject><subject>Diabetes</subject><subject>Diabetes complications</subject><subject>Diabetes mellitus</subject><subject>Diabetic nephropathy</subject><subject>Diabetic retinopathy</subject><subject>Extracellular matrix</subject><subject>Glucose</subject><subject>Kidneys</subject><subject>Meta-analysis</subject><subject>Metabolism</subject><subject>Nephropathy</subject><subject>Original</subject><subject>Retinopathy</subject><subject>Sensitivity analysis</subject><subject>Statistical analysis</subject><subject>Thrombospondin</subject><subject>Thrombospondin‐1</subject><issn>2040-1116</issn><issn>2040-1124</issn><issn>2040-1124</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp1kt9qFDEUhwdRbKm98AUk4I1ebJtkMvlzJdJaXSkIotchk5zZzTKTrMnMlt75CD5jn8Rspy5W8NwkJF--HA6_qnpJ8Bkpdb5x_owwrJon1THFDC8IoezpYU_4UXWa8waXqqXkXDyvjmohKSVSHFf5K_Rm9DHktd-iFsYbgICgh50ZwSHrk532QFihcZ3i0Ma8jcH5cPfzF0EFgz4jExzambwnE7Jx2PbezlLkA3LeFC9kNEDf-3HKL6pnnekznD6sJ9X3qw_fLj4trr98XF68v17YhuBm0TLR0Lq1rWOKG2hVJ6yzjLZWEQutJa5rrag5Nrwx4Ky0XDaOSmkZkzXB9Um1nL0umo3eJj-YdKuj8fr-IKaVNmn0tgcNhou6K68VV0xgZjpwjHGiqMMd46q43s2u7dQO5TMIYzL9I-njm-DXehV3mmCJmcK8GN48GFL8MUEe9eCzLSMxAeKUNZWC81ow1hT09T_oJk4plFlpqohoiJRkT72dKZtizgm6QzcE6300dImGvo9GYV_93f6B_BOEApzPwI3v4fb_Jv35cjkrfwNBlcaL</recordid><startdate>202402</startdate><enddate>202402</enddate><creator>Guo, Na</creator><creator>Yang, Linlin</creator><creator>Wan, Xiaozheng</creator><creator>Qiu, Dongze</creator><creator>Sun, Wenwen</creator><creator>Ma, Huijuan</creator><general>John Wiley & Sons, Inc</general><general>John Wiley and Sons Inc</general><general>Wiley</general><scope>24P</scope><scope>WIN</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7TM</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-4176-5013</orcidid><orcidid>https://orcid.org/0009-0005-3214-8995</orcidid></search><sort><creationdate>202402</creationdate><title>Relationship between elevated circulating thrombospondin‐1 levels and vascular complications in diabetes mellitus</title><author>Guo, Na ; Yang, Linlin ; Wan, Xiaozheng ; Qiu, Dongze ; Sun, Wenwen ; Ma, Huijuan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5105-b47523bcbd496aeb9f7cdc42bc91cebc1dfbc7360a65aedc8c685d288c4483103</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Apoptosis</topic><topic>Bias</topic><topic>Cardiovascular disease</topic><topic>Cardiovascular diseases</topic><topic>Case reports</topic><topic>Cell proliferation</topic><topic>Confidence intervals</topic><topic>Diabetes</topic><topic>Diabetes complications</topic><topic>Diabetes mellitus</topic><topic>Diabetic nephropathy</topic><topic>Diabetic retinopathy</topic><topic>Extracellular matrix</topic><topic>Glucose</topic><topic>Kidneys</topic><topic>Meta-analysis</topic><topic>Metabolism</topic><topic>Nephropathy</topic><topic>Original</topic><topic>Retinopathy</topic><topic>Sensitivity analysis</topic><topic>Statistical analysis</topic><topic>Thrombospondin</topic><topic>Thrombospondin‐1</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Guo, Na</creatorcontrib><creatorcontrib>Yang, Linlin</creatorcontrib><creatorcontrib>Wan, Xiaozheng</creatorcontrib><creatorcontrib>Qiu, Dongze</creatorcontrib><creatorcontrib>Sun, Wenwen</creatorcontrib><creatorcontrib>Ma, Huijuan</creatorcontrib><collection>Open Access: Wiley-Blackwell Open Access Journals</collection><collection>Wiley-Blackwell Open Access Backfiles (Open Access)</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>ProQuest_Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Journal of diabetes investigation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Guo, Na</au><au>Yang, Linlin</au><au>Wan, Xiaozheng</au><au>Qiu, Dongze</au><au>Sun, Wenwen</au><au>Ma, Huijuan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Relationship between elevated circulating thrombospondin‐1 levels and vascular complications in diabetes mellitus</atitle><jtitle>Journal of diabetes investigation</jtitle><addtitle>J Diabetes Investig</addtitle><date>2024-02</date><risdate>2024</risdate><volume>15</volume><issue>2</issue><spage>197</spage><epage>207</epage><pages>197-207</pages><issn>2040-1116</issn><issn>2040-1124</issn><eissn>2040-1124</eissn><abstract>Aims/Introduction
Thrombospondin‐1 (TSP‐1) participates in a series of physiological and pathological processes by binding to various receptors regulating cell proliferation, adhesion and apoptosis. Elevated circulating TSP‐1 is linked with diabetic vascular complications (DVC). This study aimed to determine the relationship between circulating TSP‐1 levels and DVC.
Materials and Methods
A comprehensive search of PubMed, Embase, Web of Science and CNKI databases was carried out. A meta‐analysis was carried out to compare circulating TSP‐1 levels between diabetes patients without vascular complications (DNVC), diabetes patients with DVC and non‐diabetes patients. The correlation between TSP‐1 and metabolic parameters was also analyzed. Subgroup analysis was carried out according to complication type, defined as diabetic retinopathy, diabetic nephropathy and diabetic cardiovascular disease (DCVD).
Results
A total of eight studies were included. Compared with non‐diabetes patients, diabetic patients, including DNVC and DVC, had significantly higher circulating TSP‐1 levels (standardized mean difference [SMD] 2.660, 95% CI 1.17–4.145, P = 0.000). DNVC had significantly higher circulating TSP‐1 levels than non‐diabetes patients (SMD 3.613, 95% CI 1.607–5.619, P = 0.000). DVC had significantly higher TSP‐1 levels than DNVC (SMD 0.568, 95% CI 0.100–1.036, P = 0.017). TSP‐1 was significantly positively correlated with fasting plasma glucose (overall Fisher's z = 0.696, 95% CI 0.559–0.833) and HbA1c (overall Fisher's z = 0.849, 95% CI 0.776–0.923).
Conclusions
Elevated circulating TSP‐1 levels are closely related to DVC, especially in diabetic nephropathy and diabetic cardiovascular disease. Circulating TSP‐1 detection might be helpful in the timely diagnosis and treatment of DVC.
This article studied the relationship between circulating thrombospondin‐1 levels and diabetic vascular complications by means of meta‐analysis to provide a target for the diagnosis and treatment of diabetic vascular complications</abstract><cop>Japan</cop><pub>John Wiley & Sons, Inc</pub><pmid>37822187</pmid><doi>10.1111/jdi.14095</doi><tpages>207</tpages><orcidid>https://orcid.org/0000-0002-4176-5013</orcidid><orcidid>https://orcid.org/0009-0005-3214-8995</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2040-1116 |
ispartof | Journal of diabetes investigation, 2024-02, Vol.15 (2), p.197-207 |
issn | 2040-1116 2040-1124 2040-1124 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_ea673f5d29694704afed446192d0f469 |
source | Open Access: Wiley-Blackwell Open Access Journals; Publicly Available Content (ProQuest); PubMed Central |
subjects | Apoptosis Bias Cardiovascular disease Cardiovascular diseases Case reports Cell proliferation Confidence intervals Diabetes Diabetes complications Diabetes mellitus Diabetic nephropathy Diabetic retinopathy Extracellular matrix Glucose Kidneys Meta-analysis Metabolism Nephropathy Original Retinopathy Sensitivity analysis Statistical analysis Thrombospondin Thrombospondin‐1 |
title | Relationship between elevated circulating thrombospondin‐1 levels and vascular complications in diabetes mellitus |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T12%3A48%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Relationship%20between%20elevated%20circulating%20thrombospondin%E2%80%901%20levels%20and%20vascular%20complications%20in%20diabetes%20mellitus&rft.jtitle=Journal%20of%20diabetes%20investigation&rft.au=Guo,%20Na&rft.date=2024-02&rft.volume=15&rft.issue=2&rft.spage=197&rft.epage=207&rft.pages=197-207&rft.issn=2040-1116&rft.eissn=2040-1124&rft_id=info:doi/10.1111/jdi.14095&rft_dat=%3Cproquest_doaj_%3E2876637445%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5105-b47523bcbd496aeb9f7cdc42bc91cebc1dfbc7360a65aedc8c685d288c4483103%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2917518815&rft_id=info:pmid/37822187&rfr_iscdi=true |